These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3533098)

  • 1. The manipulation of micro-organisms for the production of secondary metabolites.
    Bunch AW; Harris RE
    Biotechnol Genet Eng Rev; 1986; 4():117-44. PubMed ID: 3533098
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward a science of metabolic engineering.
    Bailey JE
    Science; 1991 Jun; 252(5013):1668-75. PubMed ID: 2047876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspectives in microbial secondary metabolism].
    Kakinuma K
    Seikagaku; 1986 Mar; 58(3):167-75. PubMed ID: 3531363
    [No Abstract]   [Full Text] [Related]  

  • 4. The production of biotin by genetically modified micro-organisms.
    Brown SW; Kamogawa K
    Biotechnol Genet Eng Rev; 1991; 9():295-326. PubMed ID: 1797017
    [No Abstract]   [Full Text] [Related]  

  • 5. Engineering primary metabolic pathways of industrial micro-organisms.
    Kern A; Tilley E; Hunter IS; Legisa M; Glieder A
    J Biotechnol; 2007 Mar; 129(1):6-29. PubMed ID: 17196287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering aspects of beta-lactam biosynthesis.
    van den Berg MA; Bovenberg RA; de Laat WT; van Velzen AG
    Antonie Van Leeuwenhoek; 1999; 75(1-2):155-61. PubMed ID: 10422588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug synthesis by genetically engineered microorganisms.
    Hutchinson CR
    Biotechnology (N Y); 1994 Apr; 12(4):375-80. PubMed ID: 7764683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The technology of genetic manipulation.
    Gibson RK
    Soc Appl Bacteriol Symp Ser; 1987; 16():7S-19S. PubMed ID: 3127890
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug development through the genetic engineering of antibiotic-producing microorganisms.
    Hutchinson CR; Borell CW; Donovan MJ; Kato F; Motamedi H; Nakayama H; Otten SL; Rubin RL; Streicher SL; Stutzman-Engwall KJ
    Ann N Y Acad Sci; 1991 Dec; 646():78-93. PubMed ID: 1809208
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene networks that regulate secondary metabolism in actinomycetes: pleiotropic regulators].
    Rabyk MV; Ostash BO; Fedorenko VO
    Tsitol Genet; 2014; 48(1):67--82. PubMed ID: 24791475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyene antibiotic biosynthesis gene clusters.
    Aparicio JF; Caffrey P; Gil JA; Zotchev SB
    Appl Microbiol Biotechnol; 2003 May; 61(3):179-88. PubMed ID: 12698274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the genetic potential of polyketide producing streptomycetes.
    Weber T; Welzel K; Pelzer S; Vente A; Wohlleben W
    J Biotechnol; 2003 Dec; 106(2-3):221-32. PubMed ID: 14651864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities for direct manipulation of gene expression of microbial secondary metabolism].
    Gräfe U
    Z Allg Mikrobiol; 1981; 21(5):373-409. PubMed ID: 7025466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of high-effective symbiotic bacteria: evolutionary models and genetic approaches].
    Provorov NA; Onishchuk OP; Iurgel' SN; Kurchak ON; Chizhevskaia EP; Vorob'ev NI; Zatovskaia TV; Simarov BV
    Genetika; 2014 Nov; 50(11):1273-85. PubMed ID: 25739280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
    Song JY; Jensen SE; Lee KJ
    Appl Microbiol Biotechnol; 2010 Oct; 88(3):659-69. PubMed ID: 20711575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antibiotic production and silent gene activation in Streptomyces diastatochromogenes by ribosome engineering.
    Shentu X; Liu N; Tang G; Tanaka Y; Ochi K; Xu J; Yu X
    J Antibiot (Tokyo); 2016 May; 69(5):406-10. PubMed ID: 26648118
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of micro-organisms for L-ascorbic acid production: current status and future perspectives.
    Hancock RD; Viola R
    Appl Microbiol Biotechnol; 2001 Sep; 56(5-6):567-76. PubMed ID: 11601603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward rational design of bacterial genomes.
    Cambray G; Mutalik VK; Arkin AP
    Curr Opin Microbiol; 2011 Oct; 14(5):624-30. PubMed ID: 21865081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The All-Union methodological seminar on "Cellular engineering of antibiotic producers"].
    Sazykin IuO
    Antibiot Khimioter; 1988 Mar; 33(3):163-4. PubMed ID: 3163913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.